Browsing Norwegian Institute of Public Health Open Repository by Author "Hamidi Ashtiani, Vida"
Now showing items 1-7 of 7
-
Continuous monitoring of pulmonary artery pressure via an implanted leadless and battery less pressure sensor for the management of patients with moderate to severe heart failure (New York Heart Association class III). A single technology assessment
Pike, Eva Flovild; Bjerkan, Anne Mette; Kvist, Beate Charlotte Fagerlund; Hamidi Ashtiani, Vida; Harboe, Ingrid; Klemp, Marianne (Research report, 2016) -
Health technology assessment of four drugs for patients with metastatic castration resistant prostate cancer
Sæterdal, Ingvil von Mehren; Desser, Arna S.; Pike, Eva Flovild; Hamidi Ashtiani, Vida; Harboe, Ingrid; Odgaard-Jensen, Jan; Klemp, Marianne (Research report, 2016) -
Medicines used for Multiple Sclerosis – A Health Technology Assessment
Couto, Elisabeth; Hamidi Ashtiani, Vida; Ringerike, Tove; Odgaard-Jensen, Jan; Harboe, Ingrid; Klemp, Marianne (Research report, 2016) -
Molecular tests for detection of PIK3CA mutations in men and postmenopausal women with HR+/HER2–, locally advanced or metastatic breast cancer: A Health Technology Assessment.
Flodgren, Gerd Monika; Hamidi Ashtiani, Vida; Meneses Echavez, Jose Francisco; Bidonde Torre, Maria Julia (Research report, 2022)Key message The Norwegian Institute of Public Health was commissioned to evaluate molecular tests for the identification of somatic PIK3CA mutations in men and postmenopausal women with HR+/HER2–, advanced or metastatic ... -
Natalizumab subkutant til behandling av relapserende remitterende multippel sklerose: forenklet metodevurdering– helseøkonomisk evaluering
Hamidi Ashtiani, Vida (Research report, 2021)Hovedbudskap: Folkehelseinstituttet (FHI) har på oppdrag fra Bestillerforum for nye metoder utarbeidet en forenklet metodevurdering hvor den helseøkonomiske modellen i den fullstendige metodevurderingen om legemidler til ... -
Tests for detection of ROS1 gene alterations in people with non-small cell lung cancer (NSCLC): A Health Technology Assessment.
Flodgren, Gerd Monika; Hamidi Ashtiani, Vida (Research report, 2021)Key messages: The Norwegian Institute of Public Health has been commissioned to evaluate molecular tests for the identification of somatic ROS1 gene alterations in people with locally advanced or metastatic non-small cell ... -
Tests for the detection of NTRK gene fusions in patients with locally advanced or metastatic solid tumours. A Health Technology Assessment
Hamidi Ashtiani, Vida; Flodgren, Gerd Monika; Meneses Echavez, Jose Francisco; Bidonde Torre, Maria Julia (Research report, 2022)Key messages The Norwegian Institute of Public Health has been commissioned to assess molecular tests for the identification of NTRK gene fusions in locally advanced or metastatic solid tumours. Less than 1% of solid ...